Become a partner

News archive

All news

2021-03-30

Inaugural “ATMP world tour” 2021

Driving International dialogue in cell and gene therapy

2021-02-16

ATMP SWEDEN NEWSLETTER FEBRUARY 2021

Catch up on the latest including Swedish COVID-19 ATMPs and the ATMP world tour 2021!

2021-02-14

SDP1 permits and standards for cellular ATMPs

Donors, manufacture, pharmacy and clinic....what permits are needed by who and from whom? What quality standards?

2021-01-19

Amniotics AB pioneer in-house ATiMP production

Tips for setting up MPA approved GMP manufacture facilities within a small cell therapy company

2020-12-16

ATMP SWEDEN NEWSLETTER DECEMBER 2020

Catch up on the latest including launch of the commercialisation resources developed by Swelife-ATMP!

2020-12-10

Launch of the SDP3 report and resources!

Find information and tools to assist in establishing your business model.

2020-12-03

EATRIS launches their ATMP course!

Develop your science, transverse skills and competencies to drive the next generation of ATMPs!

2020-11-05

MAGic Bioprocessing joins CAMP!

Together with KTH/AdBIOPRO and AstraZeneca, will explore scaleable magnetic-based cell separation

2020-10-19

ATMP Sweden baseline report summary

Where are we right now with Swedish ATMP manufacture, research and industry?

2020-09-22

Italian company VivaBioCell joins CAMP

First foreign Company to join the Swedish ATMP network

2020-09-16

NextCell Pharma AB ProTrans-2 clinical trial meets primary endpoint.

Improved preservation of insulin production over 12 months in newly diagnosed adult type-1 diabetes patients

2020-09-14

”Double” cell therapy gives new hope to malignant melanoma patients

Three severly ill patients are now long term survivors in remission

2020-09-14

ATMP Sweden Newsletter September 2020

Catch up on the latest including great results from our CAMP cell therapy project for Malignant Melanoma

2020-09-01

Manufacturing of Gene Therapy Products: A Swedish Perspective

Swelife-ATMP SDP4 releases their report on international competitiveness within Swedish gene therapy

2020-08-25

New Swedish pluripotent cell therapy partnership with Novo Nordisk

48 million SEK partnership to develop pluripotent cell based cell therapy for Dry Macular Degeneration

2020-06-29

Input welcomed on draft report on health economy and business models for ATMP

Swelife-ATMP project SDP3 invitates comments and input on implications.

2020-06-01

Now is the time for NK cells!

CellProtect Nordic Pharmaceuticals AB rebrands to XNK Therapeutics AB

2020-05-12

Swedish MPA warns against unproven cell-based therapies.

Patients and their families are cautioned against using unproven cell based therapies.

2020-04-06

Karolinska awarded Comprehensive Cancer Centre

Karolinska University Hospital and Karolinska Institutet become first Swedish CCC.

2020-04-06

GE Healthcare Life Sciences rebrands to ’Cytiva’

New Danaher operating company created following completion of $21.4B acquisition

2020-03-12

EuropaBio recommendations to support EU ATMP Innovation

Outlines and elaborating EuropaBio’s position and policy recommendations to the European Commission (EC)

2020-03-09

3MEUR for COVID19 vaccine awarded to KI

CAMP HQ plasmid and pre-GMP projects pave way for Corona vaccine project

2020-02-18

ATMP Sweden newsletter February

The latest on the 2020 conference and more

2020-02-16

Welcome to the Flemingsberg ATMP network!

Interview with network coordinator Lilian Walther Jallow

2020-01-27

Karin Hoogendoorn on LONZA and Sweden

"To keep up with the potential of this field we need to think and work innovatively, not competitively"

2020-01-08

Anna Pasetto receives prestigious award to fight cancer with T cells

Sjöberg foundation awards 6 million over 3 years to engineering of T cells against Hepatocellular Carcinoma

2020-01-08

BOOSTB4 trial in Osteogenesis Imperfecta is recruiting!

Please spread this information to those with patients relevant to this trial.

2020-01-07

Jobs: Manufacturing Scientist Cobra Bio

Applications due 31st January, 2020.

2020-01-07

What’s on in 2020!?

Find ATMP relevant events in 2020 and links to sign up!

2019-12-20

Swedish ATMP newsletter December 2019

See our newsletter here and subscribe to receive directly!

2019-12-18

The Swedish government releases their life science strategy

Focus on precision medicine and ATMP

2019-11-26

ATMP awarded Innovation Environment within the ”Vision Driven Health” program

Vinnova awards 10 million SEK over two years to secure Sweden's ATMP future

2019-11-05

Cognate Bioservices aquires Cobra Biologics

Creates global cell and gene therapy manufacturing services platform

2019-10-21

Gene therapy reduces Acute Intermittent Porphyria attacks by 79%

Promising results from Swedish study published in The New England Journal of Medicine

2019-10-17

Register before November 15th for ATMP PhD courses!

Two great courses covering some ATMP science and the field as a whole

2019-10-16

Financing ATMPs – Bedside to Reimbursement

Part 2 of our September 2019 ATMP financing events in Skåne.

2019-09-23

200 million SEK investment in Swedish gene and immunotherapy production

Cobra Biologics invests 200 million SEK in Matfors facility

2019-09-19

Swedish based Ilya Pharma recruiting for first ATMP trial

Genetically engineered bacteria to drive wound healing

2019-09-16

Financing ATMPs – Bench to Bedside

Part one of our summary of ATMP financing events in Skåne September 2019

2019-06-24

Competence centre in NK cell-based immunotherapies to be formed

A centre for development of the next generation NK cell-based immunotherapies against cancer to be built from Karolinska Institutet.

2019-06-24

External ATMP Newsletter Midsummer 2019

Register for our finance events and AdBIOPRO bioreactor course

2019-06-24

Sweden’s first GMP line registered in hPSCreg

KARO1 is the first GMP hESC line produced at Vecura, there are more to come!

2019-06-19

Register for our events in finance and partnering!

Real examples of taking ATMPs from research to market approval. Who do you need to be partnering with!?

2019-06-04

World first, Swedish gene therapy for blindness

Swedish gene therapy clinical trial for RLBP1 Retinitis Pigmentosa ongoing in Stockholm, Sweden

2019-05-23

Better skin for a better life for burns survivors

Sweden drives National and International collaboration to improve quality of life for burns survivors, saved through skin stem cell transplants

2019-05-09

External ATMP Newsletter Spring 2019

The Conference edition of our Newsletter! Read more about the success that was ATMP Sweden 2019!

2019-04-02

Sweden’s Gene and Cell therapy Industry showcased at ATMP Sweden 2019

The era of gene and cell therapy treatments is here!

2019-03-01

New national planning project

Advanced therapies for future Healthcare

2019-03-01

Melanoma gone following treatment with TILs and DC vaccination.

Good news from of one of our CAMP Projects "Expansion of GMP Compliant Tumor Infiltrating Lymphocytes (TILs) in Xuri bioreactor".

2019-03-01

Johan Hyllner Head of Cell and Gene Therapy at AZ.

We are pleased to hear that Johan Hyllner has been recruited to AstraZeneca as Head of their Cell and Gene Therapy program.

2019-02-06

Who is VOG cell and what are they doing now?

VOG (tissue area Group) cell represents a National network of University hospitals in Sweden.

2019-02-06

External ATMP Newsletter Winter 2019

It's too cold to go outside, browse our newsletter instead!

2018-11-11

Cobra focussing on development and manufacture services for ATMPs

Cobra is currently expanding capacity in both Keele, UK and Matfors, Sweden.

2018-11-11

Johan Hyllner on moving back to Sweden

We caught up with Johan to see what his plans are post Catapult.

2018-11-11

New Recruit and new Facility – KI Pre-GMP

As part of CAMP WP1/WP2 Karolinska Institutet is setting up a pre-GMP core facility.

2018-11-11

External ATMP Newsletter Autumn 2018

Welcome to the first CAMP/Swelife-ATMP quarterly ATMP newsletter!